Supply of Optune Plus Transducers

The contract involves the procurement and delivery of Optune Plus Transducers, an FDA-regulated medical device used to treat tumors through tumor-treating electric fields, to the VA Medical Center in Indianapolis. These transducers are critical components of a non-invasive therapy system prescribed for specific cancer patients, and their reliable supply is essential for ongoing patient care within the Veterans Health Administration. The agreement is structured as a subcontract under the 250-NETWORK Contract Office 10, which operates under the Department of Veterans Affairs, ensuring compliance with federal procurement standards and specialized medical equipment distribution protocols. The North American Industry Classification System code 334510 indicates that the supplier falls under the category of medical equipment and supplies manufacturing, affirming the specialized nature of the product and the technical expertise required for its production and distribution. While the solicitation number and exact place of performance details are not provided, the contract is set to be active as of May 5, 2026, and is intended to support consistent, uninterrupted access to this life-sustaining therapy for veterans receiving treatment at the designated VA facility. The absence of set-aside designation suggests the contract is open to qualified general contractors without specific socioeconomic preferences, prioritizing timely delivery and regulatory compliance over demographic sourcing requirements.